AirAnswers®’ patented technology combines ionic propulsion developed more than 5 decades ago for space travel with cutting-edge molecular biology used to detect disease in human blood and urine samples. It works at the molecular level, so we can measure the actual molecules that lead to your symptoms.
AirAnswers® collects microscopic allergens from 1 million liters of air, more than any other commercial technology.
The device can pinpoint the exact allergens at the molecular level, making it the only product that can provide the full spectrum of indoor allergens.
-
Accuracy
-
Reporting
-
Allergens vs Irritants
Unmatched Accuracy
Not all indoor air quality testing passes the grade for allergen exposure.
AirAnswers®'s collection technology collects what matters with the highest accuracy. Some air samplers measure important air quality elements, like CO2, radon, VOC, or mold. But they fall short of accurately measuring actual allergens, which are critical to an allergy or asthma sufferer.
We Report What Matters
We deliver data that are specific to your home and your family's health. AirAnswers® measures clinically relevant, invisible allergens that are inhaled through our nose and lungs to trigger symptoms.
Why are allergens different from irritants?
All people with allergic diseases are affected by a unique personal set of allergens in their environment. The allergens inflame airways, which causes greater sensitivity to irritants. Focusing on allergens is vital!
Allergens include dust mites, molds, pollens, pests, and pets. Irritants, which affect everybody, include perfumes, exhaust, and smoke.
Personalized Results & Next Steps
Allergy and asthma self-management is not one-size-fits-all. We translate results into actions. personalized to your unique environment
Our end goal is to help you solve your problem at home.
Lab Standards Used By Hospitals
Our ISO-compliant laboratory provides customers with consistent and accurate results.
We use a cutting edge immuno-assay, based on the ELISA (enzyme-linked immunosorbent assay) method, to detect allergens in your air. ELISA is a form of immunological testing that is widely performed in hospital reference laboratories on patient blood and urine specimens. Our ELISA uses a combination of antibodies designed to identify allergens in your environment. We use specialized equipment that measures the amount of allergen in your air sample, providing you with an individualized blueprint of your tested room or rooms.
Worldwide standard that medical testing laboratories must meet, to be deemed technically competent. Specialized quality systems are put in place to assure the repeatability and accuracy of results.
Our end goal is to help you solve your air problem at home.
-
Validated
-
Tested
-
Published
Lab Standards Used By Hospitals
Our ISO-compliant laboratory provides customers with consistent and accurate results.
We use a cutting edge immuno-assay, based on the ELISA (enzyme-linked immunosorbent assay) method, to detect allergens in your air. ELISA is a form of immunological testing that is widely performed in hospital reference laboratories on patient blood and urine specimens. Our ELISA uses a combination of antibodies designed to identify allergens in your environment. We use specialized equipment that measures the amount of allergen in your air sample, providing you with an individualized blueprint of your tested room or rooms.
ISO/IEC 17025: Worldwide standard that medical testing laboratories must meet, to be deemed technically competent. Specialized quality systems are put in place to assure the repeatability and accuracy of results.
Clinically and Scientifically Validated
Our research is published in major scientific journals and clinically and scientifically validated in hundreds of homes and other locations in collaboration with leading allergists, researchers and institutions, including Johns Hopkins University, University of Chicago, Harvard University and Argonne National Labs.
Published in Annals of Allergy Asthma and Immunology
Our beta trial was conducted on 22 allergy and asthma participants. After participants used AirAnswers®, their physician felt that patient management for 77% of them would be impacted by AirAnswers®'s measurements. Results suggest that AirAnswers® is a powerful tool for improving allergy and asthma management.
Published in Microbiome
Our side-by-side test was conducted with a reference method in 3 locations. AirAnswers®'s performance was determined to be equivalent to capture of reference method for microbiome analysis by quantitative PCR and amplicon sequencing.
-
"Our technology to capture any class of airborne agents has now been demonstrated by our ability to rapidly adapt to the new normal and take on monitoring of airborne COVID, or whatever else the world will throw at human populations in the future"
Julian Gordon, PhD, Co-Founder & CSO, Inspirotec -
"Our data shows proof of principle of the ability of this device to detect viral RNA in the air in the hospital, we believe this will allow us to better understand how viruses are present in the air and ultimately reduce risk of contracting COVID-19"
Jayant Pinto, MD, University of Chicago -
"The two primary sources for transmission of SARS-CoV-2, the virus that causes COVID-19, include person-to-person spread by respiratory droplets and when the virus becomes aerosolized in a confined space such as a classroom, home, business or workplace. I
Robert Leo Murphy, MD, Northwestern Medicine, Infectious diseases -
"As a certifying trade association for IAQ (indoor air quality) professionals, NORMI will incorporate AirAnswers in its training protocols because it provides a unique holistic approach to evaluating allergens and produces results that I trust.”
Doug Hoffman, Executive Director of the NORMI -
"This is a great tool that enables the Indoor Air Quality (IAQ) community to support validation of airborne health and safety protocols."
Tim Butler, General Manager for Best Living Systems -
“AirAnswers allows us to understand the air our patients are breathing, and to structure our interventions and treatment plans based on their lived reality.”
Matt Siemer, Mobile Care Chicago's Executive Director
Know your patients' environment.
It’s a new day in the fight against harmful airborne allergens. Get the answers you need.
Get AirAnswers®Researched in collaboration with
Peer reviewed literature and memberships
